Search

everythinglearnresearchcommunity

for

Search:↓

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Testosterone gel helps increase facial hair in young men with beta-thalassemia major.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

Hair testing can detect a single GHB exposure, useful for documenting sexual assault.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

GFC improves hair quickly, while PRP offers longer-lasting benefits; using both sequentially is recommended.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Targeted testing for telogen effluvium patients can save healthcare costs.

Gagamchengyoung-tang may help improve hair growth and scalp health in certain alopecia patients.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

MEGA PROTAC improves prediction and ranking of protein complexes better than existing methods.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Fragile hair in children is rarely linked to trichothiodystrophy (TTD).

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

Many transgender men on testosterone therapy experience hair loss.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

Testosterone treatment may affect heart response to stress in transgender men.

Older age increases positive hair alcohol test results, and chest hair is a good alternative for testing; season affects results, with higher levels in winter.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Early diagnosis and a multidisciplinary approach are crucial for children with Trichothiodystrophy and hidden learning disorders.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.